Manufacturers Life Insurance Company, The Zentalis Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 128,208 shares of ZNTL stock, worth $229,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128,208

Previous 128,124 0.07%

Holding current value

$229,492

Previous $470,000 17.45%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.7 - $4.03 $226 - $338	84 Added 0.07%	128,208 $388,000
Q3 2024 Nov 13, 2024	SELL	$2.9 - $4.57 $2,914 - $4,592	-1,005 Reduced 0.78%	128,124 $470,000
Q2 2024 Aug 14, 2024	SELL	$4.09 - $16.13 $10,985 - $43,325	-2,686 Reduced 2.04%	129,129 $528,000
Q1 2024 May 14, 2024	BUY	$10.83 - $16.49 $161,594 - $246,047	14,921 Added 12.76%	131,815 $2.08 Million
Q4 2023 Feb 13, 2024	BUY	$9.84 - $20.13 $260,671 - $533,263	26,491 Added 29.3%	116,894 $1.77 Million
Q3 2023 Nov 15, 2023	BUY	$19.63 - $28.29 $172,410 - $248,471	8,783 Added 10.76%	90,403 $1.81 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $322,676 - $556,946	18,534 Added 29.38%	81,620 $2.3 Million
Q1 2023 May 15, 2023	BUY	$16.14 - $24.94 $532 - $823	33 Added 0.05%	63,119 $1.09 Million
Q4 2022 Aug 11, 2023	BUY	$18.07 - $25.6 $63,714 - $90,265	3,526 Added 5.92%	63,086 $1.27 Million
Q4 2022 Feb 13, 2023	BUY	$18.07 - $25.6 $63,714 - $90,265	3,526 Added 5.92%	63,086 $1.27 Million
Q3 2022 Aug 11, 2023	SELL	$20.23 - $31.73 $6,109 - $9,582	-302 Reduced 0.5%	59,560 $1.29 Million
Q3 2022 Nov 03, 2022	SELL	$20.23 - $31.73 $6,109 - $9,582	-302 Reduced 0.5%	59,560 $1.28 Million
Q2 2022 Aug 11, 2023	SELL	$17.91 - $52.25 $178,222 - $519,939	-9,951 Reduced 14.25%	59,862 $1.68 Million
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $178,222 - $519,939	-9,951 Reduced 14.25%	59,862 $1.64 Million
Q1 2022 Aug 11, 2023	BUY	$41.58 - $80.89 $278,336 - $541,477	6,694 Added 10.61%	69,813 $3.22 Million
Q1 2022 May 20, 2022	BUY	$41.58 - $80.89 $2.14 Million - $4.16 Million	51,392 Added 278.99%	69,813 $3.19 Million
Q4 2021 Feb 16, 2022	BUY	$66.92 - $84.79 $12,112 - $15,346	181 Added 0.99%	18,421 $1.53 Million
Q3 2021 Nov 12, 2021	SELL	$46.83 - $73.5 $15,219 - $23,887	-325 Reduced 1.75%	18,240 $1.22 Million
Q2 2021 Aug 12, 2021	BUY	$37.41 - $62.25 $89,746 - $149,337	2,399 Added 14.84%	18,565 $988,000
Q1 2021 May 03, 2021	SELL	$35.69 - $52.72 $28,409 - $41,965	-796 Reduced 4.69%	16,166 $701,000
Q4 2020 Feb 12, 2021	BUY	$31.71 - $57.97 $336,918 - $615,931	10,625 Added 167.67%	16,962 $881,000
Q3 2020 Nov 09, 2020	BUY	$27.03 - $47.97 $10,866 - $19,283	402 Added 6.77%	6,337 $207,000
Q2 2020 Aug 10, 2020	BUY	$23.2 - $54.8 $137,692 - $325,238	5,935 New	5,935 $270,000

Others Institutions Holding ZNTL

# of Institutions

147

Shares Held

65.3M

Call Options Held

43.2K

Put Options Held

21.7K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $102M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Zentalis Pharmaceuticals, Inc. Transaction History